Patient Notification Regarding *Laboratory Requirements Prior to Initiating GLP-1 or Weight Loss Medications Logo
  • Patient Notification Regarding *Laboratory Requirements Prior to Initiating GLP-1 or Weight Loss Medications

    Please review this consent thoroughly
  • Purpose:
    This consent form outlines your agreement to participate in laboratory testing as part of your treatment while on weight loss medications, including GLP-1 (glucagon-like peptide-1 receptor agonists), through our telemedicine practice, BottumzUp Health & Wellness, LLC.

    1. Understanding of Weight Loss Medications
    I understand that I am being prescribed weight loss medications, such as GLP-1, as part of my treatment plan. These medications may require regular monitoring through laboratory tests to assess their effectiveness and monitor any potential side effects.

    2. Laboratory Testing

    As part of your treatment plan for GLP-1 or other weight loss medications, you may be required to complete certain laboratory tests before beginning therapy.


    *I consent to the collection of laboratory samples (e.g., blood, urine) as necessary to monitor my response to weight loss medications. These samples may be drawn by a qualified healthcare professional at a designated laboratory for analysis. Bottumzup Health and Wellness currently uses QUEST Diagnostic Labs. In the event you have your laboratory samples drawn at another facility you are responsible for submitting your results to Bottumzup Health and Wellness, LLC. These tests are essential to ensure your safety and to assess your overall health status.

    The specific laboratory requisites will be determined based on your individual health needs and may include blood tests to evaluate factors such as:

    • Baseline metabolic parameters
    • Kidney function
    • Liver function
    • Blood glucose levels, etc...

     

    3. Communication of Results
    I consent to receive laboratory results via telemedicine platforms, phone calls, or secure messaging as appropriate. I understand that my healthcare provider will discuss these results with me and how they may impact my treatment plan.

    4. Right to Withdraw Consent
    I acknowledge that I have the right to withdraw my consent for laboratory testing at any time. However, I understand that this may affect my treatment plan, as regular monitoring is important for my health while on weight loss medications.

    5. Confidentiality
    I understand that my laboratory results and related information will be kept confidential in accordance with applicable laws and regulations.

    6. Questions and Concerns
    I have had the opportunity to ask questions regarding this consent form, the laboratory testing process, and the weight loss medications, and my questions have been answered to my satisfaction.

    By signing below, I consent to the laboratory testing outlined above and acknowledge that I have read and understood this consent form.

  • Powered by Jotform SignClear
  • IMPORTANT!!---- IF YOU HAD LABWORK DONE ELSEWHERE YOU MUST EMAIL YOUR LABS TO 

    bottumzuphealthandwellness@gmail.com

  • Labs Required Prior to Starting GLP-1 Therapy:
    Before initiating GLP-1 (semaglutide) therapy, the following labs are required to ensure the patient's safety and suitability for treatment:

    Comprehensive Metabolic Panel (CMP): To assess baseline liver function, kidney function, and electrolyte levels.
    Liver Function Tests (LFTs): To screen for any existing liver abnormalities before starting therapy, as GLP-1 medications can affect liver enzymes.
    Hemoglobin A1c (HbA1c): To assess baseline glycemic control and confirm the appropriateness of GLP-1 therapy for the patient's needs.
    Thyroid Stimulating Hormone (TSH): To evaluate thyroid function as GLP-1 medications may have an impact on thyroid health.
    Lipase and Amylase: To check for any pre-existing pancreatic concerns, as GLP-1 therapy can increase the risk of pancreatitis in some patients.


    Labs Required 3–6 Months Post-GLP-1 Therapy:
    To monitor the patient’s response to therapy and to detect any potential side effects, the following labs are required 3 to 6 months after starting GLP-1 therapy:

    Comprehensive Metabolic Panel (CMP): To assess ongoing liver and kidney function, as well as electrolyte balance, particularly since changes in these parameters can occur during GLP-1 therapy.
    Liver Function Tests (LFTs): To monitor for any potential liver dysfunction, as some patients may experience elevations in liver enzymes during therapy.
    Hemoglobin A1c (HbA1c): To assess the effectiveness of GLP-1 therapy in controlling blood sugar levels.
    Lipase and Amylase: To screen for any signs of pancreatic issues, as elevated lipase levels can indicate pancreatitis, a rare but serious side effect of GLP-1 medications.


    Importance of Monitoring!!

    Liver Function: GLP-1 medications can cause temporary elevations in liver enzymes in some individuals. Routine monitoring allows early detection of any liver issues and helps prevent potential liver damage.
    Pancreatic Health: Elevated lipase levels can indicate pancreatic stress or the development of pancreatitis. Monitoring these enzymes helps to ensure early identification of any pancreatic complications.
    Kidney and Electrolyte Balance: Since GLP-1 medications can have effects on kidney function and hydration status, regular monitoring is necessary to ensure the kidneys are functioning properly and that the patient is not at risk of dehydration or electrolyte imbalances.
    Blood Sugar Control: Tracking HbA1c levels helps to assess the effectiveness of the medication in managing blood glucose and ensures that the patient is achieving the desired therapeutic outcomes.

    ***The required lab work prior to and during GLP-1 therapy is essential for the safe and effective management of treatment. By monitoring key parameters, we can ensure the patient's health is protected while achieving the desired therapeutic benefits. Regular follow-up and lab tests are important to detect any adverse effects early and make necessary adjustments to the treatment plan.

     

  • Consent Statement:
    I,   *   *   , understand the importance of the lab tests required before starting GLP-1 therapy and the follow-up labs required 3 to 6 months after starting treatment. I consent to these tests and understand that they are essential for my safety and the ongoing effectiveness of the medication.   

  • Powered by Jotform SignClear
  • Please note: Hormone panels are NOT a part of your initial basic labs

    Patient Notification Regarding Hormone Panel Testing

    As part of your comprehensive care, we may recommend a hormone panel to further assess your health.

    Please note that this testing will require a separate office visit specifically dedicated to drawing the necessary samples.

    During this visit, our provider will explain the purpose of the hormone panel, discuss any related symptoms, and ensure that you understand the process involved. It’s important to have this assessment to tailor your treatment effectively.

    If you have any questions or would like to schedule this separate visit, please don’t hesitate to contact our office.

  • Powered by Jotform SignClear
  • Should be Empty: